These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21722209)

  • 21. Tau protein phosphorylation in diverse brain areas of normal and CRH deficient mice: up-regulation by stress.
    Filipcik P; Novak P; Mravec B; Ondicova K; Krajciova G; Novak M; Kvetnansky R
    Cell Mol Neurobiol; 2012 Jul; 32(5):837-45. PubMed ID: 22222439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    Planel E; Yasutake K; Fujita SC; Ishiguro K
    J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Dependent Effects of Mild Blast-induced Traumatic Brain Injury on Corticotropin-releasing Factor Receptor Gene Expression: Potential Link to Anxiety-like Behaviors.
    Russell AL; Handa RJ; Wu TJ
    Neuroscience; 2018 Nov; 392():1-12. PubMed ID: 30248435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide.
    Gardner LE; White JD; Eimerbrink MJ; Boehm GW; Chumley MJ
    Neuroscience; 2016 Sep; 331():72-7. PubMed ID: 27320209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of repeated restraint stress on energy balance and behavior of mice with selective deletion of CRF receptors.
    Chotiwat C; Kelso EW; Harris RB
    Stress; 2010 May; 13(3):203-13. PubMed ID: 20392192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.
    Yoshida S; Maeda M; Kaku S; Ikeya H; Yamada K; Nakaike S
    J Neural Transm (Vienna); 2006 Nov; 113(11):1803-14. PubMed ID: 16855914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid.
    Shan Y; Wang DD; Xu YX; Wang C; Cao L; Liu YS; Zhu CQ
    J Alzheimers Dis; 2016; 49(3):829-44. PubMed ID: 26577520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
    Carroll JC; Iba M; Bangasser DA; Valentino RJ; James MJ; Brunden KR; Lee VM; Trojanowski JQ
    J Neurosci; 2011 Oct; 31(40):14436-49. PubMed ID: 21976528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation induced by infection potentiates tau pathological features in transgenic mice.
    Sy M; Kitazawa M; Medeiros R; Whitman L; Cheng D; Lane TE; Laferla FM
    Am J Pathol; 2011 Jun; 178(6):2811-22. PubMed ID: 21531375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade.
    Ohkubo N; Lee YD; Morishima A; Terashima T; Kikkawa S; Tohyama M; Sakanaka M; Tanaka J; Maeda N; Vitek MP; Mitsuda N
    FASEB J; 2003 Feb; 17(2):295-7. PubMed ID: 12490540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
    J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β.
    Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ
    Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin-releasing factor augments LPS-induced immune/inflammatory responses in JAWSII cells.
    Hu Y; Li M; Lu B; Wang X; Chen C; Zhang M
    Immunol Res; 2016 Apr; 64(2):540-7. PubMed ID: 26754762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells.
    Yoon SY; Park JS; Choi JE; Choi JM; Lee WJ; Kim SW; Kim DH
    Neurobiol Dis; 2010 Nov; 40(2):449-55. PubMed ID: 20655383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.
    Kitazawa M; Oddo S; Yamasaki TR; Green KN; LaFerla FM
    J Neurosci; 2005 Sep; 25(39):8843-53. PubMed ID: 16192374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
    Martin L; Page G; Terro F
    Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.